Ranitidine Tablets, USP 150 mg, a.) 95 count bottles (NDC 43598-808-62), b.) 220 count bottles (NDC 43598-808-65) (HCA) OTC.
Recall Number: D-0176-2020
Firm: Dr. Reddy's Laboratories, Inc.
Classification: Class II
Status: Completed
Report Date: 20191113
Initiation Date: 20191001
Termination Date:
Reason for Recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Product Description
Ranitidine Tablets, USP 150 mg, a.) 95 count bottles (NDC 43598-808-62), b.) 220 count bottles (NDC 43598-808-65) (HCA) OTC.